Michael O'Riordan

Choosing between Pascal and MitraClip comes down to patient anatomy, with both devices working well in most cases.

The reason for the disparity is unknown but is not believed to be genetic. Female athletes appear to be at the lowest risk.

The new data may spark fresh debate over alcohol's once-celebrated cardioprotective benefits: not everyone is convinced.

Complication rates, including bleeding, were significantly lower when the radial artery was used over a second femoral puncture.

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

The device was not included as a potential treatment despite sham-controlled evidence showing it reduces patient symptoms.

The proportion of female speakers increased over time, but they remain underrepresented in procedural and other specialties.

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

In a field rife with disagreement, STS, AATS, and others say the European guidelines got it right when it comes to CABG.